Procter & Gamble Company (The) $PG Shares Bought by Woodmont Investment Counsel LLC

Woodmont Investment Counsel LLC raised its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 88,890 shares of the company’s stock after purchasing an additional 2,556 shares during the quarter. Procter & Gamble comprises 0.9% of Woodmont Investment Counsel LLC’s investment portfolio, making the stock its 27th biggest position. Woodmont Investment Counsel LLC’s holdings in Procter & Gamble were worth $14,162,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC boosted its stake in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC purchased a new position in Procter & Gamble during the first quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. boosted its stake in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Assenagon Asset Management S.A. boosted its stake in Procter & Gamble by 140.4% during the first quarter. Assenagon Asset Management S.A. now owns 2,663,246 shares of the company’s stock worth $453,870,000 after buying an additional 1,555,504 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Up 0.1%

Shares of NYSE:PG opened at $152.19 on Monday. The firm’s 50 day moving average price is $155.51 and its 200 day moving average price is $159.95. The stock has a market cap of $356.20 billion, a price-to-earnings ratio of 23.38, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm’s revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is 64.82%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 8,596 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the sale, the chief executive officer owned 64,991 shares of the company’s stock, valued at approximately $10,221,134.57. This trade represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sundar G. Raman sold 9,554 shares of the company’s stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the completion of the transaction, the chief executive officer owned 41,886 shares of the company’s stock, valued at approximately $6,624,689.76. The trade was a 18.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 over the last quarter. Insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on PG shares. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Wells Fargo & Company reduced their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. BNP Paribas reissued an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Barclays reduced their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $173.11.

Read Our Latest Stock Analysis on Procter & Gamble

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.